Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.05 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |